Bed Bath and Beyond gets rare buy rating, but 2 traders wouldn’t bite


Bed Bath and Beyond may be beyond reach.

Though the retailer got a rare buy rating this week from B. Riley, which initiated the name with a $44 price target and an optimistic case for its new management and cost-cutting strategies, the stock doesn’t look particularly appealing at its current levels, two traders told CNBC’s “Trading Nation” on Thursday.

The $3.5 billion company’s earnings and revenue growth forecasts may look better than those of its industry peers, but still falls short relative to the broader market, Chantico Global founder and CEO Gina Sanchez said in the Thursday interview.

“It’s really hard to get excited,” she said. “We think that they’re priced about right and this…


0 0 votes
Article Rating

Walgreens, Didi, CureVac & more

Previous article

Tesla Model 3 regains safety endorsements from Consumer Reports, IIHS

Next article

You may also like

Notify of
Inline Feedbacks
View all comments

More in Retail